Japanese researchers say the Omicron variant survives longer on plastic and skin than other COVID-19 variants, one possible explanation for why Omicron has spread so rapidly around the world.
than other COVID-19 variants, one possible explanation for why Omicron has spread so rapidly around the world.
In a lab experiment, samples of different variants were applied to pieces of plastic and human skin collected from autopsies, researchers from Kyoto Prefectural University of Medicine wrote in“This study showed that the Omicron variant also has the highest environmental stability among VOCs , which suggests that this high stability might also be one of the factors that have allowed the Omicron variant to replace theOn plastic, the Omicron variant samples survived an average of 193.
On skin samples, the Omicron samples survived an average of 21.1 hours. The other variants had these average survival times on skin: 8.6 hours for the original version, 19.6 hours for Alpha, 19.1 hours for Beta, 11 hours for Gamma, and 16.8 hours for Delta. The study found that the variants had more resistance to ethanol than the original strain of COVID. That said, all COVID samples were inactivated after being exposed to alcohol-based hand sanitizers for 15 seconds.
"Therefore, it is highly recommended that current infection control practices use disinfectants ... as proposed by the World Health Organization," the researchers said.BioRxiv: “Differences in environmental stability among SARS-CoV-2 variants of concern: Omicron has higher stability.”
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
COVID-19 live updates: New Zealand imposes restrictions amid omicron outbreakNew Zealand Prime Minister Jacinda Ardern revealed that her own wedding will be postponed as she announced a new set of COVID-19 restrictions amid the country’s first omicron outbreak.
Baca lebih lajut »
FDA Curbs Use of COVID-19 Antibody Drugs Sidelined by OmicronU.S. health officials say COVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they are unlikely to work against the omicron variant.
Baca lebih lajut »
Pfizer, BioNTech begin omicron-specific COVID-19 vaccine studyCOVID-19 vaccine-makers Pfizer and BioNTech announced Tuesday that the companies would test an omicron-specific vaccine candidate in healthy adults ages 18 to 55.
Baca lebih lajut »
COVID-19 live updates: WHO warns of rising cases of omicron sub-variantWhite House press sec. Jen Psaki calls Florida Gov. DeSantis' opposition to FDA decision limiting monoclonal antibody treatments found to be ineffective against omicron 'crazy,' says he is advocating for treatments 'that don't work.'
Baca lebih lajut »
Stealth omicron: New COVID-19 sub-variant seen in 40 countriesThe subvariant could be more contagious, scientists say.
Baca lebih lajut »
Pfizer says it's starting clinical studies of an omicron-based COVID-19 vaccinePfizer and BioNTech said Tuesday they've stated clinical trials for an omicron-based COVID-19 vaccine.
Baca lebih lajut »